APP and Alzheimer disease: Acute and intermittent hypoxia have been associated with AD exacerbation involving e.g., increased β-site APP-cleaving enzyme 1 (BACE1) levels, altered APP processing, induced autophagy and increased Aβ accumulation [9–15].